Inventor · disambiguated record
William A. Nugent
Also filed as: NUGENT JR WILLIAM A · NUGENT JR WILLIAM ALOYSIUS · NUGENT WILLIAM A · NUGENT WILLIAM ALOYSIUS
26 granted patents·4 pending applications·248 citations·filing 1982–2022
96Inventor score
Files withVERTEX PHARMA11DU PONT9BRISTOL MYERS SQUIBB CO3ALIOS BIOPHARMA INC2BRISTOL MYERS SQUIBB PHARMA1
Top patents by PatentIndex Score
30 records- 0197US4774353ATriorganotin catalyst promoters for hydrocyanationDU PONT·Filed 1986·Granted Sep 27, 1988·92 cites·6 claims
- 0296US10071979B2Process of producing cycloalkylcarboxamido-indole compoundsVERTEX PHARMA·Filed 2015·Granted Sep 11, 2018·29 cites·28 claims
- 0392US11434201B2Processes for preparing pyrrolidine compoundsVERTEX PHARMA·Filed 2018·Granted Sep 6, 2022·6 cites·22 claims
- 0491US9856284B2Solid forms of a thiophosphoramidate nucleotide prodrugALIOS BIOPHARMA INC·Filed 2016·Granted Jan 2, 2018·5 cites·20 claims
- 0590US6187918B1Catalysts for asymmetric addition of organozinc reagents to aldehydes and method for preparationDU PONT PHARM CO·Filed 2000·Granted Feb 13, 2001·20 cites·7 claims
- 0689US10023569B2Methods of preparing inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Jul 17, 2018·9 cites·19 claims
- 0788US6362344B1Catalysts for asymmetric addition of organozinc regents to aldehydes and method for preparationBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Mar 26, 2002·17 cites·6 claims
- 0887US11465985B2Processes for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2018·Granted Oct 11, 2022·6 cites·8 claims
- 0986US9394330B2Solid forms of a thiophosphoramidate nucleotide prodrugALIOS BIOPHARMA INC·Filed 2014·Granted Jul 19, 2016·7 cites·43 claims
- 1085US4451665AProcess for dimerizing acrylates and methacrylatesDU PONT·Filed 1982·Granted May 29, 1984·19 cites·10 claims
- 1183US8916538B2Solid forms of a thiophosphoramidate nucleotide prodrugVERTEX PHARMA·Filed 2013·Granted Dec 23, 2014·5 cites·28 claims
- 1281US10640501B2Methods of preparing inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2018·Granted May 5, 2020·1 cites·10 claims
- 1376US12415798B2Processes for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Granted Sep 16, 2025·0 cites·5 claims
- 1468US8378124B2Preparation of protected alpha-keto beta-amino esters and amidesVERTEX PHARMA·Filed 2010·Granted Feb 19, 2013·1 cites·7 claims
- 1568US4709085ACyclopropanation processDU PONT·Filed 1987·Granted Nov 24, 1987·8 cites·12 claims
- 1668US2021238158A1Process of producing cycloalkylcarboxamido-indole compoundsVERTEX PHARMA·Filed 2020·Application pending·0 cites
- 1767US11345700B2Methods of preparing inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2020·Granted May 31, 2022·0 cites·6 claims
- 1865US5516953AProcess for the preparation of optically active cycloolefinsDU PONT·Filed 1994·Granted May 14, 1996·9 cites·14 claims
- 1960US5043510AAqueous alkylation processDU PONT·Filed 1989·Granted Aug 27, 1991·6 cites·4 claims
- 2060US2019210991A1Process of producing cycloalkylcarboxamido-indole compoundsVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 2149US6207847B1Manufacture of optically active halohydrin trialkylsilyl ethersDU PONT·Filed 1998·Granted Mar 27, 2001·4 cites·7 claims
- 2247US7507838B2Process for the preparation of Z-5-carboxymethylene-1,3-dioxolan-4-onesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Mar 24, 2009·0 cites·16 claims
- 2347US2013131356A1Preparation of protected alpha-keto beta-amino esters and amidesVERTEX PHAMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2443US7015320B2Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactamsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Mar 21, 2006·0 cites·12 claims
- 2541US6555686B2Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB PHARMA·Filed 2001·Granted Apr 29, 2003·0 cites·44 claims
- 2640US6924397B2Process for the preparation of α-chloroketones from alkyl estersBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 2, 2005·0 cites·47 claims
- 2735US5231203AEnantioselective lewis acid catalysts of the early transition metalsDU PONT·Filed 1991·Granted Jul 27, 1993·4 cites·26 claims
- 2833US2001044540A1Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitorsFiled 2001·Application pending·0 cites
- 2931US5559268AProcess for the efficient preparation of N-substituted dehydroamino acid estersDU PONT·Filed 1994·Granted Sep 24, 1996·0 cites·8 claims
- 3027US5352836AEnantioselective lewis acid catalysts of the early transition metalsDU PONT·Filed 1993·Granted Oct 4, 1994·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →